Drug Type Small molecule drug |
Synonyms 头孢他啶他唑巴坦钠 |
Target |
Action inhibitors |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), β-lactamase inhibitors(Beta Lactamase inhibitors), Cell wall inhibitors |
Therapeutic Areas |
Inactive Indication- |
Originator Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (15 Mar 2010), |
Regulation- |
Molecular FormulaC22H24N6O8S2 |
InChIKeyGCZOCVAKBHTGOL-ROMZVAKDSA-N |
CAS Registry78439-06-2 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Infectious Diseases | China | 15 Mar 2010 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Genitourinary tract infection | Phase 2 | China | 09 Feb 2012 | |
Respiratory Tract Infections | Phase 2 | China | 09 Feb 2012 |